De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

GE HealthCare Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

GE HealthCare Technologies heeft een totaal eigen vermogen van $8.0B en een totale schuld van $9.2B, wat de schuld-eigenvermogensverhouding op 115.6% brengt. De totale activa en totale passiva bedragen respectievelijk $31.9B en $23.9B. De EBIT GE HealthCare Technologies is $2.9B waardoor de rentedekking 5.6 is. Het heeft contanten en kortetermijnbeleggingen van $2.0B.

Belangrijke informatie

115.6%

Verhouding schuld/eigen vermogen

US$9.24b

Schuld

Rente dekkingsratio	5.6x
Contant	US$2.00b
Aandelen	US$7.99b
Totaal verplichtingen	US$23.86b
Totaal activa	US$31.85b

Recente financiële gezondheidsupdates

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

May 21

Recent updates

GE HealthCare: The Image Of More Upside Is Very Real

Sep 18

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

Sep 05

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

Apr 25

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

Apr 02

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

Mar 25

GE HealthCare Technologies' Roar Higher Isn't Over Yet

Mar 09

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Feb 14

GE HealthCare Q4 Earnings: Growth Lagging The Market

Feb 06

Why GE HealthCare May Be Up To 50% Undervalued

Jan 11

GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital

Jan 05

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $8.8B ) GEHC } overtreffen de korte termijn passiva ( $8.3B ).

Langlopende schulden: De kortetermijnactiva van GEHC ( $8.8B ) dekken de langetermijnschulden ( $15.5B ) niet.

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: De netto schuld/eigen vermogen ratio ( 90.6% ) GEHC wordt als hoog beschouwd.

Schuld verminderen: Er zijn onvoldoende gegevens om te bepalen of de schuld/eigen vermogen-ratio van GEHC de afgelopen 5 jaar is gedaald.

Schuldendekking: De schuld van GEHC wordt goed gedekt door de operationele kasstroom ( 21.6% ).

Rentedekking: De rentebetalingen op de schuld van GEHC worden goed gedekt door EBIT ( 5.6 x dekking).

GE HealthCare Technologies Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

Recent updates

GE Healthcare Announces FDA Approval of Flyrcado (Flurpiridaz F 18) Injection Pet Radiotracer for Enhanced Diagnosis of Coronary Artery Disease

Second quarter dividend of US$0.03 announced

GE HealthCare Introduces Elevated Venue Point of Care Ultrasound Solutions and New Tablet-Based Venue Sprint

GE HealthCare: The Image Of More Upside Is Very Real

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

Are Investors Undervaluing GE HealthCare Technologies Inc. (NASDAQ:GEHC) By 28%?

GE HealthCare Technologies Inc. Showcases Latest AI-Enhanced Cardiology Solutions to Enable Real-Time Cardiac Imaging and Assessments At the Point of Care At ESC 2024

GE HealthCare Announces the Publication of the MASTER Trial Results in the Peer-Reviewed Journal Anesthesia and Analgesia

Insider recently sold US$1.6m worth of stock

GE HealthCare Q2 Earnings Recap (Rating Downgrade)

Second quarter 2024 earnings: EPS exceeds analyst expectations

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

GE Healthcare Technologies Inc. Updates Earnings Guidance for the Year 2024

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q2, 2024 Results on Jul 31, 2024

GE HealthCare: Near-Term Risks, But Some Interesting Longer-Term Opportunities

First quarter dividend of US$0.03 announced

GE HealthCare Technologies Inc. Announces Cash Dividend for Second Quarter of 2024, Payable on August 15, 2024

GE Healthcare Names Adam Holton as Chief People Officer

Is GE HealthCare Technologies (NASDAQ:GEHC) A Risky Investment?

President & CEO of Imaging notifies of intention to sell stock

GE HealthCare Unveils SIGNA MAGNUS, an FDA 510(K) Pending Head-Only Magnetic Resonance (MR) Scanner Designed to Explore Advance Advancements in Neuro Science

GE HealthCare: Too Soon To Buy After A Mixed Q1 (Rating Downgrade)

GE HealthCare Launches New Era of AI-Enhanced, Personalized Oncology Solutions at ESTRO 2024 Congress

First quarter 2024 earnings: EPS and revenues miss analyst expectations

GE HealthCare Technologies Inc. Reaffirms Earnings Guidance for the Full Year 2024

GE HealthCare Technologies Inc.'s (NASDAQ:GEHC) Intrinsic Value Is Potentially 100% Above Its Share Price

GE HealthCare Introduces AI-Enhanced Voluson Signature 20 and 18 Ultrasound Systems to Advance Women's Health Imaging

Upcoming dividend of US$0.03 per share

GE HealthCare Technologies Inc. to Report Q1, 2024 Results on Apr 30, 2024

GE HealthCare Technologies Inc., Annual General Meeting, May 21, 2024

GE Healthcare Introduces Caption AI on Vscan Air SL Wireless Handheld Ultrasound System to Help More Clinicians Capture Diagnostic-Quality Cardiac Images

GE Vernova: An Interesting Stalwart To Ride The Energy Transition

GE HealthCare Unveils AI-Enabled Urology Software Feature Prostate Volume Assist

GE HealthCare Technologies: Growth Prospects Remain Encouraging, And Valuation Is Attractive

GE HealthCare Technologies Inc. to Feature Latest Technologies in Interventional Radiology Focused on Precision Care At Sir 2024

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies' Roar Higher Isn't Over Yet

GE HealthCare Technologies Inc. has completed a Follow-on Equity Offering in the amount of $1.06925 billion.

GE HealthCare Technologies Inc. has filed a Follow-on Equity Offering.

GE HealthCare Technologies: Stable Business, But Future Upside Seems Limited

Price target increased by 7.6% to US$90.21

Full year 2023 earnings: EPS misses analyst expectations

Now 33% overvalued after recent price rise

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Full Year of 2024

GE HealthCare Q4 Earnings: Growth Lagging The Market

GE HealthCare Technologies Inc. Receives 510(K) Clearance from the United States Food and Drug Administration for Novii™+ Wireless Patch Solution

GE HealthCare Technologies Inc. Announces Prucka 3 Digital Amplifier as Next Generation Platform for Electrophysiology Innovation

GE HealthCare Technologies Inc. to Report Q4, 2023 Results on Feb 06, 2024

Why GE HealthCare May Be Up To 50% Undervalued

GE HealthCare Technologies Inc. (NasdaqGS:GEHC) entered into definitive agreement to acquire MIM Software Inc.

GE HealthCare Technologies (NASDAQ:GEHC) May Have Issues Allocating Its Capital

Upcoming dividend of US$0.03 per share at 0.2% yield

GE HealthCare Highlights Commitment to Delivering Better Patient Experiences and Outcomes Through Deep Learning at RSNA 2023

GE HealthCare Expands On-Device Triage Capabilities of Critical Care Suite with FDA Clearance of Algorithm for Pneumothorax Detection, Notification, Triage and Diagnosis

GE HealthCare Technologies Inc. Releases MyBreastAI Suite to Support Clinicians in Accelerating Breast Cancer Detection

GE Healthcare Announces New Data Validating Artificial Intelligence Models for Predicting Patient Response to Immunotherapies

GE HealthCare Technologies Inc. Provides Earnings Guidance for the Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven